Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Condition:   Metastatic Breast CancerIntervention:   Sponsor:   AHS Cancer Control AlbertaTerminated - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials